Cargando…
Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195321/ https://www.ncbi.nlm.nih.gov/pubmed/32363137 http://dx.doi.org/10.1016/j.apsb.2020.04.013 |
_version_ | 1783528509033938944 |
---|---|
author | Bian, Jingwei Zhao, Rongsheng Zhai, Suodi Li, Zijian |
author_facet | Bian, Jingwei Zhao, Rongsheng Zhai, Suodi Li, Zijian |
author_sort | Bian, Jingwei |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7195321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-71953212020-05-02 Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection Bian, Jingwei Zhao, Rongsheng Zhai, Suodi Li, Zijian Acta Pharm Sin B Letter to the Editor Elsevier 2020-07 2020-04-28 /pmc/articles/PMC7195321/ /pubmed/32363137 http://dx.doi.org/10.1016/j.apsb.2020.04.013 Text en © 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Letter to the Editor Bian, Jingwei Zhao, Rongsheng Zhai, Suodi Li, Zijian Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection |
title | Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection |
title_full | Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection |
title_fullStr | Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection |
title_full_unstemmed | Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection |
title_short | Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection |
title_sort | letter to the editor: anti-ras drugs and sars-cov-2 infection |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195321/ https://www.ncbi.nlm.nih.gov/pubmed/32363137 http://dx.doi.org/10.1016/j.apsb.2020.04.013 |
work_keys_str_mv | AT bianjingwei lettertotheeditorantirasdrugsandsarscov2infection AT zhaorongsheng lettertotheeditorantirasdrugsandsarscov2infection AT zhaisuodi lettertotheeditorantirasdrugsandsarscov2infection AT lizijian lettertotheeditorantirasdrugsandsarscov2infection |